Condensed Consolidated Statements of Stockholders' Equity (Deficit) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2013	$ (11,463,965)	$ 1,000	$ 1,000	$ (11,465,965)
Balance (in shares) at Dec. 31, 2013	999,999	999,999
Increase (Decrease) in Stockholders' Equity
Sale of common stock in our initial public offering	17,728,815	3,105	17,725,710
Sale of common stock in our initial public offering (in shares)		3,105,000
Offering costs of our initial public offering	(2,388,027)		(2,388,027)
Fair value of warrants issued in connection with our initial public offering	901,185		901,185
Conversion of convertible notes	9,400,000	2,787	9,397,213
Conversion of convertible notes (in shares)		2,787,667
Write -off of derivative liability upon conversion of notes payable	5,526,003		5,526,003
Issuance of common stock from vesting of restricted stock units, net of shares used to pay taxes	38,824	5	38,819
Issuance of common stock from vesting of restricted stock units, net of shares used to pay taxes (in shares)		5,029
Fair value of stock options issued to advisors and consultants	211,801		211,801
Sale of warrants	1,000		1,000
Stock-based compensation	249,775		249,775
Net loss	(7,293,641)			(7,293,641)
Balance at Jun. 30, 2014	$ 12,911,770	$ 6,897	$ 31,664,479	$ (18,759,606)
Balance (in shares) at Jun. 30, 2014	6,897,695	6,897,695